Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% ... firms had partnered on a potential bid for B+L, which sells contact lenses as well as ophthalmic pharmaceuticals ...

Bausch & Lomb Corp.’s stock soared ... consumer eye-care business and higher sales of SiHy Daily lenses and Ultra within the contact-lens business. That was partially offset by unfilled orders ...

Bausch + Lomb. “In the U.S., where enVista Aspire is currently available, surgeons and their patients appreciate the features of these monofocal lenses that are designed for a broader depth of ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX ... portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic ...

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...